Omega Therapeutics Stock Price, News & Analysis
Company Description
Omega Therapeutics (NASDAQ: OMGA) is a publicly traded biological product (except diagnostic) manufacturing company in the Biological Products, (no Disgnostic Substances) sector. The company has a market capitalization of $7.9M, ranking #6,528 among all listed U.S. companies by market cap.
OMGA stock has declined 96.4% over the past year. Shares last traded at $0.1426.
This page provides a comprehensive overview of OMGA stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Omega Therapeutics (OMGA) stock last traded at $0.1426. Over the past 12 months, the stock has lost 96.4%. At a market capitalization of $7.9M, OMGA is classified as a micro-cap stock with approximately 55.4M shares outstanding.
Latest News
Omega Therapeutics has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 8 with negative movement. Key topics include management, earnings, clinical trial, conferences. View all OMGA news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
OMGA Company Profile & Sector Positioning
Omega Therapeutics (OMGA) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Biological Products, (no Disgnostic Substances) sector and is listed on the NASDAQ.